Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 141 publications
Pirtobrutinib in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Journal: Future oncology (London, England)
Published: October 03, 2025
Venetoclax-Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview.
Journal: Cancers
Published: September 04, 2025
BTK inhibitors potently impair platelet aggregation as a class effect independent of BTK specificity or dose in CLL and MCL.
Journal: Journal of clinical and experimental hematopathology : JCEH
Published: July 30, 2025
Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 29, 2025
Bruton Tyrosine Kinase Inhibitors in Mantle Cell Lymphoma: What Are the Current Options?
Journal: European journal of haematology
Published: July 26, 2025
Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted Therapy.
Journal: Genes
Published: July 25, 2025
Triplet Therapies in Chronic Lymphocytic Leukemia.
Journal: Hematology/oncology clinics of North America
Published: July 24, 2025
Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia.
Journal: Hematology/oncology clinics of North America
Published: July 17, 2025
Resistance to Bruton Tyrosine Kinase Inhibitors.
Journal: Hematology/oncology clinics of North America
Published: July 11, 2025
Erratum: Phase III Trial of Pirtobrutinib Versus Idelalisib/Rituximab or Bendamustine/Rituximab in Covalent Bruton Tyrosine Kinase Inhibitor-Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-321).
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 27, 2025
Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment.
Journal: Current treatment options in oncology
Published: June 17, 2025
Last Updated: 10/31/2025